第 1 到 17 筆結果,共 17 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Pyrazinamide related prolonged drug-induced liver injury: A case report | Wang, Yeh-Chin; KAI-HSIANG CHEN; YEN-LIN CHEN ; SHU-WEN LIN ; WANG-DA LIU ; JANN-TAY WANG ; CHIEN-CHING HUNG | Medicine | 4 | 4 | |
2 | 2021 | Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression | Huang, Wei-Chieh; Huang, Chun-Kai; Huang, Sung-Hsi; SHU-WEN LIN ; Ou, Shyh-Tyan; YI-TING CHEN ; Chen, Ya-Wen; Chang, Shu-Yuan; Liu, Wen-Chun; HSIN-YUN SUN ; CHIEN-CHING HUNG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 1 | 1 | |
3 | 2021 | Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide | Liou, Bo-Huang; Cheng, Chih-Ning; Lin, Ya-Ting; Lin, Yu-Jou; YU-CHUNG CHUANG ; KUAN-YIN LIN ; Liu, Wen-Chun; SHU-WEN LIN ; CHING-HUA KUO ; HSIN-YUN SUN ; CHIEN-CHING HUNG | Journal of the International AIDS Society | 8 | 9 | |
4 | 2021 | Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV | Huang, Sung-Hsi; Huang, Wei-Chieh; SHU-WEN LIN ; YU-CHUNG CHUANG ; HSIN-YUN SUN ; SUI-YUAN CHANG ; Kuo, Po-Hsien; Wu, Pei-Ying; Liu, Wen-Chun; Chiang, Chieh; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of acquired immune deficiency syndromes (1999) | 5 | 4 | |
5 | 2020 | Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study | Huang S.-H.; SHU-WEN LIN ; SUI-YUAN CHANG ; Lin Y.-T.; HSIN-YUN SUN ; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 4 | 4 | |
6 | 2020 | Implementation and outcomes of a therapeutic drug monitoring program for antifungal and antiretroviral agents in a tertiary medical center in Taiwan | SHU-WEN LIN ; CHING-HUA KUO ; LI-JIUAN SHEN ; YEE-CHUN CHEN ; CHIEN-CHING HUNG ; FE-LIN LIN WU | JACCP Journal of the American College of Clinical Pharmacy | 2 | 1 | |
7 | 2017 | Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients | YU-SHAN HUANG ; CHIEH-KAI CHAN ; Tsai M.-S.; Lee K.-Y.; SHU-WEN LIN ; SUI-YUAN CHANG ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 12 | 8 | |
8 | 2017 | Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study | Tsai M.-S.; SUI-YUAN CHANG ; SHU-WEN LIN ; CHING-HUA KUO ; HSIN-YUN SUN ; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 5 | 3 | |
9 | 2017 | Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy | Huang S.-H.; SHU-WEN LIN ; SUI-YUAN CHANG ; Lin Y.-T.; Chiang C.; Hsiao C.-F.; HSIN-YUN SUN ; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Scientific Reports | 7 | 7 | |
10 | 2016 | Use of hypoprothrombinemia-inducing cephalosporins and the risk of hemorrhagic events: A nationwide nested case-control study | Chen L.-J.; FEI-YUAN HSIAO ; LI-JIUAN SHEN ; FE-LIN LIN WU ; WOEI TSAY ; CHIEN-CHING HUNG ; SHU-WEN LIN | PLoS ONE | 30 | 19 | |
11 | 2015 | Presence of tablet remnants of nevirapine extended-release in stools and its impact on virological outcome in HIV-1-infected patients: A prospective cohort study | Lee Y.-C.; SHU-WEN LIN ; Chen M.-Y.; SUI-YUAN CHANG ; CHING-HUA KUO ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; HSIN-YUN SUN ; Chang H.-Y.; Wu M.-R.; Liu W.-C.; Wu P.-Y.; Yang S.-P.; Zhang J.-Y.; Su Y.-C.; Luo Y.-Z.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | PLoS ONE | 1 | 0 | |
12 | 2015 | Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy | KUAN-YIN LIN ; SIH-HAN LIAO ; Liu W.-C.; ARISTINE CHENG ; SHU-WEN LIN ; SUI-YUAN CHANG ; Tsai M.-S.; CHING-HUA KUO ; Wu M.-R.; HSIU-PO WANG ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | PLoS ONE | 14 | 10 | |
13 | 2014 | Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan | Tseng Y.-T.; Yang C.-J.; SUI-YUAN CHANG ; SHU-WEN LIN ; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | International Journal of Infectious Diseases | 12 | 10 | |
14 | 2014 | Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: Incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia | Yang J.-J.; Huang C.-H.; Liu C.-E.; Tang H.-J.; Yang C.-J.; Lee Y.-C.; Lee K.-Y.; Tsai M.-S.; SHU-WEN LIN ; Chen Y.-H.; Lu P.-L.; CHIEN-CHING HUNG | PLoS ONE | 31 | 32 | |
15 | 2014 | Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia | Lai C.-C.; Lee K.-Y.; SHU-WEN LIN ; Chen Y.-H.; HAN-YUEH KUO ; CHIEN-CHING HUNG ; PO-REN HSUEH | Expert Review of Anti-Infective Therapy | 9 | 10 | |
16 | 2014 | Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy | Lee K.-Y.; SHU-WEN LIN ; HSIN-YUN SUN ; CHING-HUA KUO ; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; SUI-YUAN CHANG ; CHIEN-CHING HUNG | PLoS ONE | 24 | 25 | |
17 | 2009 | Do we still need lead-in dosing of Nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy? | SUI-YUAN CHANG ; SHU-WEN LIN ; CHIEN-CHING HUNG | Clinical Infectious Diseases | 3 | 1 |